Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study

被引：0
|
作者：
Calabrese, Joseph [1 ]
Sanchez, Raymond [1 ]
Jin, Na [1 ]
Amatniek, Joan [1 ]
Cox, Kevin [1 ]
Johnson, Brian [1 ]
Perry, Pamela P. [1 ]
Hertel, Peter [1 ]
Such, Pedro [1 ]
Salzman, Phyllis M. [1 ]
McQuade, Robert D. [1 ]
Nyilas, Margaretta [1 ]
Carson, William H. [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2016年 / 41卷
关键词：
Bipolar I Disorder; Aripiprazole Once-Monthly; Maintenance Treatment; Long-Acting Injectable Antipsychotic;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T116
引用
收藏
页码：S360 / S361
页数：2
相关论文
共 50 条
  • [31] Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study
    Findling, Robert L.
    Robb, Adelaide
    McNamara, Nora K.
    Pavuluri, Mani N.
    Kafantaris, Vivian
    Scheffer, Russell
    Frazier, Jean A.
    Rynn, Moira
    DelBello, Melissa
    Kowatch, Robert A.
    Rowles, Brieana M.
    Lingler, Jacqui
    Martz, Karen
    Anand, Ravinder
    Clemons, Traci E.
    Taylor-Zapata, Perdita
    PEDIATRICS, 2015, 136 (05) : 885 - 894
  • [32] Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: A multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole
    Ishigooka, Jun
    Nakamura, Jun
    Fujii, Yasuo
    Iwata, Nakao
    Kishimoto, Toshifumi
    Iyo, Masaomi
    Uchimura, Naohisa
    Nishimura, Ryoji
    Shimizu, Naoaki
    SCHIZOPHRENIA RESEARCH, 2015, 161 (2-3) : 421 - 428
  • [33] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder - A second multicenter, randomized, double-blind, placebo-controlled study
    Marcus, Ronald N.
    McQuade, Robert D.
    Carson, William H.
    Hennicken, Delphine
    Fava, Maurizio
    Simon, Jeffrey S.
    Trivedi, Madhukar H.
    Thase, Michael E.
    Berman, Robert M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (02) : 156 - 165
  • [34] Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study
    Torres, Rosarelis
    Czeisler, Emily L.
    Chadwick, Sean R.
    Stahl, Stephen M.
    Smieszek, Sandra P.
    Xiao, Changfu
    Polymeropoulos, Christos M.
    Birznieks, Gunther
    Polymeropoulos, Mihael H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2024, 85 (01)
  • [35] ALL-CAUSE DISCONTINUATION AND SAFETY OF ARIPIPRAZOLE ONCE-MONTHLY FOR THE TREATMENT OF SCHIZOPHRENIA: A POOLED ANALYSIS OF TWO DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIALS
    Eramo, Anna
    Fleischhacker, W. Wolfgang
    Sanchez, Raymond
    Tsai, Lan-Feng
    Peters-Strickland, Timothy S.
    Baker, Ross A.
    Kostic, Dusan
    Kane, John M.
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S174 - S174
  • [36] ALL-CAUSE DISCONTINUATION AND SAFETY OF ARIPIPRAZOLE ONCE-MONTHLY FOR THE TREATMENT OF SCHIZOPHRENIA: A POOLED ANALYSIS OF TWO DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIALS
    Baker, R.
    Fleischhacker, W. W.
    Sanchez, R.
    Tsai, L. F.
    Peters-Strickland, T.
    Eramo, A.
    Kostic, D.
    Kane, J.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [37] Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Sachs, Gary S.
    Ice, Kathleen S.
    Chappell, Phillip B.
    Schwartz, Jeffrey H.
    Gurtovaya, Oksana
    Vanderburg, Douglas G.
    Kasuba, Bryce
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (10) : 1413 - 1422
  • [38] Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study
    Fleischhacker, W. Wolfgang
    Sanchez, Raymond
    Perry, Pamela P.
    Jin, Na
    Peters-Strickland, Timothy
    Johnson, Brian R.
    Baker, Ross A.
    Eramo, Anna
    McQuade, Robert D.
    Carson, William H.
    Walling, David
    Kane, John M.
    BRITISH JOURNAL OF PSYCHIATRY, 2014, 205 (02) : 135 - 144
  • [39] Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study
    Le Xiao
    Qian Zhao
    An-ning Li
    Jushui Sun
    Bin Wu
    Lina Wang
    Honggeng Zhang
    Ruiling Zhang
    Keqing Li
    Xiaojin Xu
    Tiebang Liu
    Wenshun Zhang
    Shiping Xie
    Xiufeng Xu
    Yunlong Tan
    Kerang Zhang
    Hongyan Zhang
    Nianhong Guan
    Mingji Xian
    Motomichi Uki
    Gang Wang
    Psychopharmacology, 2022, 239 : 243 - 251
  • [40] Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study
    Xiao, Le
    Zhao, Qian
    Li, An-ning
    Sun, Jushui
    Wu, Bin
    Wang, Lina
    Zhang, Honggeng
    Zhang, Ruiling
    Li, Keqing
    Xu, Xiaojin
    Liu, Tiebang
    Zhang, Wenshun
    Xie, Shiping
    Xu, Xiufeng
    Tan, Yunlong
    Zhang, Kerang
    Zhang, Hongyan
    Guan, Nianhong
    Xian, Mingji
    Uki, Motomichi
    Wang, Gang
    PSYCHOPHARMACOLOGY, 2022, 239 (01) : 243 - 251
12345